Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Arbutus Biopharma (ABUS) - P/B ratio
P/B ratio as of May 2024 : 4.55
According to Arbutus Biopharma
's latest financial reports the company has a price-to-book ratio of 4.55.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Arbutus Biopharma - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.95 | 48.44% |
| 2022-12-31 | 2.66 | -20.61% |
| 2021-12-31 | 3.36 | 13.51% |
| 2020-12-31 | 2.96 | 19.41% |
| 2019-12-31 | 2.48 | 126.34% |
| 2018-12-31 | 1.09 | -28.22% |
| 2017-12-31 | 1.52 | 130.23% |
| 2016-12-31 | 0.6619 | 49.27% |
| 2015-12-31 | 0.4434 | -88.52% |
| 2014-12-31 | 3.86 | 50.55% |
| 2013-12-31 | 2.56 | 47.91% |
| 2012-12-31 | 1.73 | -50.46% |
| 2011-12-31 | 3.50 | -22.7% |
| 2010-12-31 | 4.53 | 104.23% |
| 2009-12-31 | 2.22 | 477% |
| 2008-12-31 | 0.3843 | -79.78% |
| 2007-12-31 | 1.90 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -239.30% | Bahamas |
 NRC Health
NRC | 17.1 | 274.39% | 🇺🇸 USA |